August 2023
COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Exploring the Pathogenicity of COVID-19 Spike Protein
Reference: Parry, P. I., Lefringhausen, A., Turni, C., Neil, C. J., Cosford, R., Hudson, N. J., & Gillespie, J. (2023). ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA. Biomedicines, 11(8), 2287. https://doi.org/10.3390/biomedicines11082287 Summary: The article discusses the pathogenicity of the COVID-19 spike protein, termed ‘spikeopathy’, derived from both the virus and
COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses
Exploring the Pathophysiology of COVID-19 Vaccine Adverse Events
Reference: Du Preez, H. N., Lin, J., Maguire, G. E. M., Aldous, C., & Kruger, H. G. (2023). COVID-19 vaccine adverse events: Evaluating the pathophysiology from an undersulfated and degraded glycocalyx perspective. ESSOAR. https://doi.org/10.22541/essoar.169203072.26336613/v1 Summary: This literature review investigates the severe adverse events associated with DNA and mRNA COVID-19 vaccines, despite their efficacy. It emphasises
COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses
Practical Ivermectin Guidelines Powerpoint Presentation
References: Powerpoint Presentation of Practical Guidelines for the therapeutic use of Ivermectin citing various publications. Compiled 2023, Dr Stephen J Schmidt. Summary: A powerpoint presentation highlighting the history of Avermectins and consequent development of the therapeutic drug commonly known as Ivermectin. The uses for various medical conditions are listed, as well as suggested protocol for